Biotherapy Services
PrivateLast Round
Series A
Extension
Jul 8, 2021
Total Funding Raised
$5.93M
Company Overview
Biotherapy Services is a biopharmaceutical company that develops regenerative therapies for wound care. The company's main product is RAPID™ Biodynamic Haematogel, a wound treatment for complex wounds like diabetic foot ulcers, which uses a patient's own blood to accelerate healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biotherapy Services Comparables
Compare Biotherapy Services with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RedDress | 77% | |
| Nuo Therapeutics Inc | 64% | |
| RION | 63% |
Biotherapy Services Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 8, 2021 | ||||
| Series A | Nov 12, 2019 |
Biotherapy Services Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foresight Enterprise VCT | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 737% MoM, from 215 to 1.8K.
- Jul 8, 2021
$2M round led by Foresight Group Holdings plc
Biotherapy Services Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biotherapy Services's valuation, stock price, and market status.
Is Biotherapy Services a public or private company?
Biotherapy Services is a private company.
What is the current stock price of Biotherapy Services?
Biotherapy Services is a private company, so its shares have no public market price. Caplight tracks Biotherapy Services's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biotherapy Services worth (valuation)?
Valuation information for Biotherapy Services is not publicly available.
Can I buy Biotherapy Services stock?
Biotherapy Services shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biotherapy Services's last funding round?
Biotherapy Services's most recent funding round was Series A Extension on July 8, 2021.
Who are the main investors in Biotherapy Services?
Key investors in Biotherapy Services include Foresight Enterprise VCT.
Will Biotherapy Services IPO soon?
No public IPO plans have been announced for Biotherapy Services.
How can I track Biotherapy Services secondary market activity?
Caplight tracks bids, offers, and trades in Biotherapy Services's shares on secondary markets.